Drug Discovery Demands AI Beyond Language Models
Beyond Language: Why Drug Discovery Needs a Different Kind of AI. Guest editorial by Woody Sherman of PsiThera. https://t.co/HsLyEcZqil
Orexin Therapies Unlock New Horizons Beyond Narcolepsy
Orexin drugs for narcolepsy and more. Listen to Richard Pops @popsalks discuss the emerging opportunity, and his 35-year-career, on The Long Run. Sponsored by @AlphaSenseInc & Dash Bio. https://t.co/Qr6oJ8AwzB
AI Accelerates Small Molecule Synthesis, Says Martin Burke
Small molecule synthesis made faster for the AI era: Listen to Martin Burke on The Long Run. Sponsors: @AlphaSenseInc and Dash Bio. https://t.co/D990phgzg8
PhaseV Sponsors Timmerman Traverse for Young Cancer Researchers
PhaseV Steps Up for Young Cancer Researchers. New Major Sponsor of Timmerman Traverse for Damon Runyon Cancer Research Foundation. Next trip: Sierras, Aug. 2-5. https://t.co/lvbuUGj0A6
Two Cancer Startups Secure $237M for Antibody Innovations
A couple cool cancer drug startups profiled this week in TR. Sidewinder Therapeutics with $137M for bispecific ADCs https://t.co/tJcQwI7C4U and Stipple Bio with $100M for novel targets for antibody drugs. https://t.co/rbXkuaRpoe
CEO Kazimi Explores Computation, Chemistry, Culture in Drug Discovery
Computation, Chemistry & Culture for Drug Discovery: Nimbus Therapeutics CEO Abbas Kazimi is the latest guest on The Long Run. Sponsored by @AlphaSenseInc and Dash Bio. https://t.co/XCysW6El1o
Nature-Inspired Drug Discovery Discussed on The Long Run
Inspired by Mother Nature, Discovering New Drugs. @viswacolluru of @lifeschemistry is the latest guest on The Long Run. Sponsored by @AlphaSenseInc and Dash Bio. https://t.co/F01HMam6Ul
Europe's Biotech Funding Gap Spurs Urgent Investment Push
Europe's Biotech Investing Crisis: @OtelloVC Otello Stampacchia of Omega Funds discusses the drive to increase EU biotech investment on The Long Run. Sponsored by @AlphaSenseInc & Dash Bio https://t.co/ORIeN8IDEq
Alumni Share Timmerman Traverse Experience – Join Now
Join the Timmerman Traverse. WATCH alumni Ted Love, Amy Abernethy, Doug Fambrough and Bonnie Anderson. https://t.co/49ZC5b4mKy
T‑cell Engagers Offer New Autoimmunity Treatment Opportunity
T-cell engagers for autoimmunity. Listen to Ken Song describe the opportunity as CEO of San Diego-based Candid Therapeutics. Sponsored by @AlphaSenseInc & Dash Bio. https://t.co/Ct2viH00c4
New Drug Discoveries Target Cancer and Autoimmunity
Discovering Drugs for Cancer and Autoimmunity. Listen to @Satpathology on The Long Run podcast. Sponsored by @AlphaSenseInc Dash Bio. https://t.co/02keVFdqzj
Timmerman Traverse Reaches $1M Milestone, Kilimanjaro Countdown
Timmerman Traverse for Damon Runyon Cancer Research Foundation has hit its $1M goal. One month to go before Kilimanjaro. https://t.co/xb01xFyZoG